Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Clin Oncol. Aug 10, 2014; 5(3): 412-424
Published online Aug 10, 2014. doi: 10.5306/wjco.v5.i3.412
Table 2 First generation gene expression signatures
Gene signatureMammaPrintOncotypeDXMapQuantDXBreast cancer ındexPAM 50 assay
Starting materialFF or stabilized RNA, FFPEFFPEFFPE, FFFFPEFFPE
Analytical platformMicroarray, RT-PCRqRT-PCRMicroarray, qRT-PCRqRT-PCRnCounter
Number of genes702197/9750
IndicationsStage I/II, 5 cm, ER (+), Node (-)/[1-3 Node (+)]ER(+), Node (-)ER (+), G2ER (+)All, Node (-) untreated
ApplicationClinical outcomeClinical outcome, benefit from chemotherapyMolecular grading prediction of response to TMXClinical outcome, prediction of response to TMXSubtype definition, risk of relapse without treatment
FDA approvedYesNoNoNoNo
ASCO and NCCN recommendationNoYesNoNoNo